These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of angiotensin converting enzyme inhibitor on cardiovascular response to lower body negative pressure [proceedings]. Adigun SA; Clough D; Conway J; Hatton R J Physiol; 1980 Jan; 298():30P-31P. PubMed ID: 6153719 [No Abstract] [Full Text] [Related]
7. [Inhibition of the renin-angiotensin system in treating arterial hypertension]. Fagard R; Leuven KU; Staessen J; Amery A Ter Arkh; 1982; 54(11):68-70. PubMed ID: 6186041 [No Abstract] [Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors for the prevention and treatment of cardiovascular disease. Frishman WH Heart Dis; 2000; 2(3):183-4. PubMed ID: 11794142 [No Abstract] [Full Text] [Related]
9. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril. Ferrari R Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572 [TBL] [Abstract][Full Text] [Related]
10. Endothelin-converting enzyme inhibitors: their application in cardiovascular diseases. Cerdeira AS; Brás-Silva C; Leite-Moreira AF Rev Port Cardiol; 2008 Mar; 27(3):385-408. PubMed ID: 18551924 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme inhibitor-induced renal dysfunction: recommendations for prevention. Cooke HM; De Besse A Int J Clin Pharmacol Ther; 1994 Feb; 32(2):65-70. PubMed ID: 8004361 [TBL] [Abstract][Full Text] [Related]
13. [Therapy of hypertensive heart disease: vasodilator agents in the forefront]. Bolli P; Bühler FR Ther Umsch; 1984 Feb; 41(2):150-5. PubMed ID: 6200947 [No Abstract] [Full Text] [Related]
14. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C; Eur Heart J; 2004 Aug; 25(16):1454-70. PubMed ID: 15302105 [No Abstract] [Full Text] [Related]
15. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors. Weinberg MS; Weinberg AJ; Zappe DH J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029 [No Abstract] [Full Text] [Related]
16. [Use of aspirin in patients taking angiotensin converting enzyme inhibitors]. Altin T; Kiliçkap M Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():14-9. PubMed ID: 18160362 [TBL] [Abstract][Full Text] [Related]
17. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases]. Ferrari R; Ambrosio G; Chiariello M Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511 [No Abstract] [Full Text] [Related]
18. [Inhibitors of angiotensin-converting enzyme in the treatment of arterial hypertension]. Salvetti A; Pedrinelli R; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S Cardiologia; 1984; 29(1-2):103-20. PubMed ID: 6085475 [No Abstract] [Full Text] [Related]
19. Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension. Waller PC; McInnes GT Br Med J (Clin Res Ed); 1987 Mar; 294(6574):769. PubMed ID: 3032326 [No Abstract] [Full Text] [Related]
20. Failure of chronic administration of the angiotensin I-converting enzyme inhibitor, Teprotide (SQ 20881), to affect the ultrastructure of the adrenal cortex and the aldosterone secretion in the rat. Weaver J; Nickerson PA; Molteni A; Solliday N; Albertson D Lab Invest; 1981 Dec; 45(6):527-33. PubMed ID: 6172661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]